you are in demo mode.    to view your own genetic profile, order your scan now.

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

Age Related Macular Degeneration

Age-related macular degeneration is a disease of the eye and a leading cause of vision impairment for people over 60 years of age. Genetic factors contribute significantly to the development of AMD.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity: 

Gender:   

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

change

Male

Trait_male_female

change


Amd
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 0.58. This corresponds to a 4.6% lifetime risk of developing age related macular degeneration, which is 42% less than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 46 of every 1000 males of European ancestry with your genotype variants develop this disease in their lifetime.
Amd
The average lifetime risk
On average, about 80 of every 1000 males of European ancestry develop this disease in their lifetime.
Amd

Consult with our experts


Need something clarified? If so, please feel free to contact our experts. Based on the nature of your questions, we may refer you to a genetic counselor.

ask a question about Age Related Macular Degeneration

Keep in mind


These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).